Acr Hybrid Analysis: Blinded Data from the Ongoing Phase IIb Trial with the EP4 Receptor Antagonist CR6086 in DMARD-Naive Patients with Early Rheumatoid Arthritis
ARTHRITIS & RHEUMATOLOGY(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ARTHRITIS & RHEUMATOLOGY(2018)